Prof. Wise Young, Chairman of Mononuclear Therapeutics shared the far-reaching impact of the public cord blood bank in aiding tens of thousands of patients, in view of the high demand for cellular therapeutics of neurological diseases. Prof. Wise Young, Chairman of Mononuclear Therapeutics shared the far-reaching impact of the public cord blood bank in aiding tens of thousands of patients, in view of the high demand for cellular therapeutics of neurological diseases.
Prof. Wise Young, Chairman of Mononuclear Therapeutics shared the far-reaching impact of the public cord blood bank in aiding tens of thousands of patients, in view of the high demand for cellular therapeutics of neurological diseases.

Mononuclear Therapeutics earns AABB accreditation for Hong Kong’s first public cord blood mononuclear cell bank

Topic |   Mononuclear Therapeutics
Prof. Wise Young, Chairman of Mononuclear Therapeutics shared the far-reaching impact of the public cord blood bank in aiding tens of thousands of patients, in view of the high demand for cellular therapeutics of neurological diseases. Prof. Wise Young, Chairman of Mononuclear Therapeutics shared the far-reaching impact of the public cord blood bank in aiding tens of thousands of patients, in view of the high demand for cellular therapeutics of neurological diseases.
Prof. Wise Young, Chairman of Mononuclear Therapeutics shared the far-reaching impact of the public cord blood bank in aiding tens of thousands of patients, in view of the high demand for cellular therapeutics of neurological diseases.
READ FULL ARTICLE